Skull base lymphoma with panhypopituitarism

Lancet Oncol. 2020 Aug;21(8):e405. doi: 10.1016/S1470-2045(20)30221-7.

Authors

Marvin Rios¹, Matthew P Wahl¹, Debra L Simmons¹, Amnon Schlegel²

Affiliations

¹ Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Utah School of Medicine, Salt Lake City, UT, USA.
² Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: [email protected].

PMID: 32758478
DOI: 10.1016/S1470-2045(20)30221-7

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Hypopituitarism / etiology*
Lymphoma / complications
Lymphoma / drug therapy
Lymphoma / pathology*
Male
Skull Base Neoplasms / complications
Skull Base Neoplasms / drug therapy
Skull Base Neoplasms / pathology*